Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
letter
. 2020 Mar 22;82(5):e177. doi: 10.1016/j.jaad.2020.03.036

COVID-19 can present with a rash and be mistaken for dengue

Beuy Joob a,, Viroj Wiwanitkit b,c
PMCID: PMC7156802  PMID: 32213305

To the Editor: We found the report “What are we doing in the dermatology outpatient department amidst the raging of 2019-CoV?” to be very interesting.1 Chen et al pointed out the need for a dermatology department to recognize and deal with this infection.

We would like to share our experience from Thailand, the second country in which the COVID-19 infection occurred since early January 2020.2 At present (March 5, 2020), there are 48 accumulated COVID-19 cases in Thailand. Among these 48 cases, there was an interesting case in which the patient presented with a skin rash with petechiae. Because dengue is very common in our setting, petechiae rash is a common clinical finding in dengue, and the patient also had low platelet count, a clinical diagnosis of dengue was made by the first physician in charge. There was no photograph and a biopsy was not done because biopsy is not a routine practice according to dengue clinical practice guidelines in our tropical setting. The patient was initially misdiagnosed as dengue, which resulted in a delayed diagnosis.3

In this case, the patient further presented respiratory problems and was referred to the tertiary medical center. Other common virus infections that might cause fever, rash, and respiratory problem were ruled out by laboratory investigation, and the final diagnosis of COVID-19 infection was confirmed by RT-PCR.

There is a possibility that a patient with COVID-19 might initially present with a skin rash that can be misdiagnosed as another common disease. In addition, some of these patients are afebrile initially.4 The practitioner should recognize the possibility that the patient might have only a skin rash and think of this disease to prevent transmission.

Footnotes

Funding sources: None.

Conflicts of interest: None disclosed.

IRB approval status: Not applicable.

Accepted for publication March 17, 2020.

References

  • 1.Chen Y., Pradhan S., Xue S. What are we doing in the dermatology outpatient department amidst the raging of the 2019 novel coronavirus. J Am Acad Dermatol. 2020;82:1034. doi: 10.1016/j.jaad.2020.02.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Yasri S., Wiwanitkit V. Editorial: Wuhan coronavirus outbreak and imported case. Adv Trop Med Pub Health Int. 2019;9:1–2. [Google Scholar]
  • 3.Joob B., Wiwanitkit V. COVID-19 in medical personnel: observation from Thailand. J Hosp Infect. 2020 doi: 10.1016/j.jhin.2020.02.016. [Epub ahead of print] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Huang C., Wang Y., Li X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of the American Academy of Dermatology are provided here courtesy of Elsevier

RESOURCES